Article Details

Ochre Bio raises $9.6m to advance RNA therapies for liver diseases

Retrieved on: 2021-06-17 11:15:00

Tags for this article:

Click the tags to see associated articles and topics

Ochre Bio raises $9.6m to advance RNA therapies for liver diseases. View article details on hiswai:

Excerpt

The funding round was led by Khosla Ventures alongside participants from Backed VC, Apollo Health Ventures, Selvedge, Hoxton and Hermes-Epitek ...

Article found on: www.epmmagazine.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up